Gabriele Armbrecht

Gabriele Armbrecht

Auto-generated profile, based on publicly available information

Gabriele Armbrecht

Centre for Muscle and Bone Research, Department of Radiology, Charite-Universitatsmedizin Berlin

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in RMD Open
Verified
Journal Article
Open access
PDF file
RDRoswitha Dietzel
Roswitha Dietzel
SWSabine Wiegmann
Sabine Wiegmann
DBDiana Borucki
Diana Borucki
CDChristian Detzer
Christian Detzer
KZKim Nikola Zeiner
Kim Nikola Zeiner
GAGabriele Armbrecht
Gabriele Armbrecht
Objective In rheumatoid arthritis (RA), chronic inflammation can enhance the development of sarcopenia with a depletion of muscle mass, strength and performance. Currently, a consensus definition for sarcopenia and solid results for the prevalence of sarcopenia in patients with RA are lacking. Methods In this cross-sectional study, 289 patients ≥18 years with RA were recruited. Dual X-ray absorptiometry was performed to measure appendicular lean mass. Assessment of muscle function included grip strength, gait speed and chair rise time. Prevalence of sarcopenia was defined using the updated European Working Group on Sarcopenia in Older People (EWGSOP2) and the Foundation for the National Institutes of Health (FNIH) definition. In addition, the RA study population was compared with existing data of healthy controls (n=280). Results 4.5% of patients (59.4±11.3 years) and 0.4% of controls (62.9±11.9 years) were affected by sarcopenia according to the EWGSOP2 definition. Body weight (OR 0.92, 95% CI 0.86 to 0.97), body mass index (BMI) (OR 0.70, 95% CI 0.57 to 0.87), C reactive protein (CRP) (OR 1.05, 95% CI 1.01 to 1.10), disease duration (OR 1.08, 95% CI 1.02 to 1.36), current medication with glucocorticoids (OR 5.25, 95% CI 2.14 to 24.18), cumulative dose of prednisone equivalent (OR 1.04, 95% CI 1.02 to 1.05) and Health Assessment Questionnaire (HAQ) (OR 2.50, 95% CI 1.27 to 4.86) were associated with sarcopenia in patients with RA. In contrast, the prevalence was 2.8% in patients compared with 0.7% in controls when applying the FNIH definition, and body height (OR 0.75, 95% CI 0.64 to 0.88), BMI (OR 1.20, 95% CI 1.02 to 1.41), CRP (OR 1.06, 95% CI 1.01 to 1.11) and HAQ (OR 2.77, 95% CI 1.17 to 6.59) were associated with sarcopenia. Conclusion Sarcopenia is significantly more common in patients with RA compared with controls using the EWGSOP2 criteria. The FNIH definition revealed sarcopenia in individuals with high BMI and fat mass, regardless of the presence of RA. Trial registration number It was registered at the German Clinical Trials Registry (DRKS) as well as WHO Clinical Trials Registry (ICTRP) (DRKS00011873, registered on 16 March 2017).

9 August 2021 in JBMR Plus
Verified
Journal Article
Open access
PDF file
GAGabriele Armbrecht
Gabriele Armbrecht
HMHuong Nguyen Minh
Huong Nguyen Minh
JMJonas Massmann
Jonas Massmann
KRKay Raum
Kay Raum
Osteoporosis is a disorder of bone remodeling leading to reduced bone mass, structural deterioration, and increased bone fragility. The established diagnosis is based on the measurement of areal bone mineral density by dual‐energy X‐ray absorptiometry (DXA), which poorly captures individual bone loss and structural decay. Enlarged cortical pores in the tibia have been proposed to indicate structural deterioration and reduced bone strength in the hip. Here, we report for the first time the in vivo assessment of the cortical pore‐size distribution together with frequency‐dependent attenuation at the anteromedial tibia midshaft by means of a novel ultrasonic cortical backscatter (CortBS) technology. We hypothesized that the CortBS parameters are associated with the occurrence of fragility fractures in postmenopausal women (n = 55). The discrimination performance was compared with those of DXA and high‐resolution peripheral computed tomography (HR‐pQCT). The results suggest a superior discrimination performance of CortBS (area under the receiver operating characteristic curve [AUC]: 0.69 ≤ AUC ≤ 0.75) compared with DXA (0.54 ≤ AUC ≤ 0.55) and a similar performance compared with HR‐pQCT (0.66 ≤ AUC ≤ 0.73). CortBS is the first quantitative bone imaging modality that can quantify microstructural tissue deteriorations in cortical bone, which occur during normal aging and the development of osteoporosis. © 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

17 March 2025 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PDF file
MKMelanie Kistler-Fischbacher
Melanie Kistler-Fischbacher
GGGhazala Gohar
Ghazala Gohar
CMCaroline de Godoi Rezende Costa Molino
Caroline de Godoi Rezende Costa Molino
KGKatharina Geiling
Katharina Geiling
TMTatjana Meyer-Heim
Tatjana Meyer-Heim
HBHeike A. Bischoff-Ferrari
Heike A. Bischoff-Ferrari
Background: Mini Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) are validated and frequently used screening tools for cognitive function. Aims: To present MMSE and MoCA scores by sex, age and education among community-dwelling older adults. Methods: This is a post-hoc observational analysis using data from the DO-HEALTH trial, which included generally healthy adults (≥ 70 years) from Switzerland, Germany, Austria, France, and Portugal who scored at least 24 points on the MMSE at baseline. We present MMSE and MoCA scores overall and by country, sex, age (70–74 years, ≥ 75 years), education (≤ and > median education years). Results: 2151 DO-HEALTH participants (mean age 74.9 years, 57% aged 70–74 years, 62% women) were included. The median (IQR) years of education was 12 (10–15), median MMSE score was 29 (28–30) and median MoCA score was 26 (23–28) points. In subgroups by sex, age, and education, the median MMSE score remained 29 for all subgroups, except for participants with shorter education (≤ 12 years) and higher age (≥ 75), who scored 28 points. For MoCA, the median score in subgroups ranged from 24 to 27 points. Participants with shorter education (≤ 12 years) and higher age (≥ 75) had lowest scores (men 24, women 25 points). Conclusions: We provide MMSE and MoCA scores for generally healthy, community-dwelling older adults from Switzerland, Germany, Austria, France and Portugal. The median MMSE and MoCA scores differed with age and education, and – less consistently – with sex. Trial registration: International Trials Registry (clinicaltrials.gov; registration ID: NCT01745263), registered December 2012.

1 March 1998 in Medizinische Klinik
Verified
Journal Article
Closed access
PDF file
DFDieter Felsenberg
Dieter Felsenberg
EDEvos-Gruppe In Deutschland
Evos-Gruppe In Deutschland
EWEberhardt Wieland
Eberhardt Wieland
CHChristine Hammermeister
Christine Hammermeister
GAGabriele Armbrecht
Gabriele Armbrecht
HRHeiner Raspe
Heiner Raspe

1 November 2001 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
MLM. Lunt
M. Lunt
WGW. Gowin
W. Gowin
OJO. Johnell
O. Johnell
GAG. Armbrecht
G. Armbrecht
DFD. Felsenberg
D. Felsenberg
OGon behalf of the EPOS study group
on behalf of the EPOS study group

1 June 2025 in Health Psychology
Verified
Journal Article
Closed access
NLNoemi Lorbeer
Noemi Lorbeer
RSRalf Schwarzer
Ralf Schwarzer
JKJan Keller
Jan Keller
SMSally Di Maio
Sally Di Maio
ADAntonia Domke
Antonia Domke
NKNina Knoll
Nina Knoll
A health action process approach (HAPA)-based intervention was designed to support moderate-to-vigorous physical activity (MVPA) in individuals with osteoarthritis of the knee (OAK). In secondary analyses of the randomized controlled trial "preventing the impairment of primary osteoarthritis by high-impact long-term physical exercise regimen-psychological adherence program," we examined long-term effects of the intervention on HAPA determinants and MVPA, and explored the former as mediators of change. N = 241 individuals with OAK (63% women, aged 44-80 years) were randomly assigned to the 12-month intervention condition (IC) or active control condition (CC). Between 2016 and 2020, self-reported HAPA determinants (action and coping planning, maintenance and recovery self-efficacy, action control) and collaborative planning were assessed at 0, 6, 12, 18, and 24 months, accelerometer-assessed MVPA at 0, 12, and 24 months. Multilevel and manifest path models were fit. Compared to the CC, action planning was higher in the IC at 6, 12, and 24 months. Maintenance and recovery self-efficacy were stable in the IC but decreased in the CC. MVPA decreased in both conditions. More action planning in the IC at 12 months was related to higher MVPA at 24 months, but, as in all other models, the indirect effect was nonsignificant. The intervention partly stabilized or enhanced HAPA determinants but did not increase MVPA in a Western, highly-educated sample with OAK. Future work might use blended-care approaches enriched by mobile applications for continuous MVPA support. (PsycInfo Database Record (c) 2024 APA, all rights reserved).